SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001104659-21-023226
Filing Date
2021-02-16
Accepted
2021-02-16 09:57:48
Documents
1
Group Members
HEIGHTS CAPITAL MANAGEMENT, INC.

Document Format Files

Seq Description Document Type Size
1 SC 13G/A tm216476d31_sc13ga.htm SC 13G/A 58557
  Complete submission text file 0001104659-21-023226.txt   60245
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Subject) CIK: 0001130166 (see all company filings)

IRS No.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-80136 | Film No.: 21633688
SIC: 2834 Pharmaceutical Preparations

Mailing Address P.O. BOX 309 UGLAND HOUSE GRAND CAYMAN E9 KY1-1104
Business Address P.O. BOX 309 UGLAND HOUSE GRAND CAYMAN E9 KY1-1104 345-949-8080
CVI Investments, Inc. (Filed by) CIK: 0001649553 (see all company filings)

IRS No.: 981253664 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G/A